Status:
UNKNOWN
Study of the Treatment and Outcomes in Critically Ill Patients With COVID-19 and High Risk of Acute Kidney Injury
Lead Sponsor:
Guy's and St Thomas' NHS Foundation Trust
Collaborating Sponsors:
Harvard Medical School (HMS and HSDM)
Conditions:
COVID
Acute Kidney Injury
Eligibility:
All Genders
18+ years
Brief Summary
The aim is to describe the epidemiology and determine the independent risk factors for mortality and acute organ injury in AKI and to assess the impact of different treatment strategies on survival. T...
Detailed Description
Since the outbreak of coronavirus disease 2019 (COVID-19) began in December 2019 in China, over 1 million people have been infected and over 55,000 have died worldwide, and these numbers continue to r...
Eligibility Criteria
Inclusion
- Adults (aged ≥18 years)
- Confirmed diagnosis of COVID-19
- Hospitalized in the ICU for illness related to COVID-19
- Any of the following:
- Current in-patient in ICU
- Previous in-patient in ICU and died in ICU or hospital
- Previous in-patient in ICU and discharged from ICU alive
Exclusion
- Younger than 18 years old
- On chronic dialysis within the last year or on dialysis at ICU admission
- Functioning kidney transplant
- No creatinine within 48 hours of ICU admission
Key Trial Info
Start Date :
June 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04445259
Start Date
June 20 2020
End Date
December 31 2022
Last Update
August 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guy's & St Thomas' Hospital
London, United Kingdom, SE1 7EH